Gossamer Bio, Inc. (GOSS) Dividend History

Gossamer Bio, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing therapies primarily for rare, serious, and underserved diseases. The company's pipeline includes innovative treatments in areas such as immunology, inflammation, and oncology, aiming to address unmet medical needs through novel scientific approaches.

3013 Science Park, San Diego, CA, 92121
Phone: (858) 922-0718
Website: https://www.gossamerbio.com

Dividend History

Gossamer Bio, Inc. currently does not pay dividends

Company News

Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight

The article discusses the evolving landscape of rare cardiovascular diseases, including Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy. It highlights the challenges in diagnosis and treatment, as well as the growing market size and pipeline of new therapies for these conditions.

GlobeNewswire Inc.

Featured Companies: ABBV CPIX INSM JNJ KNSA LQDA MRK TENX THC UTHR
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

XOMA Royalty Corporation has acquired Pulmokine Inc. for $20 million, adding the royalty and milestone interest in seralutinib, a Phase 3 asset being studied for pulmonary arterial hypertension, to its portfolio.

Benzinga

Featured Companies: XOMA XOMAO XOMAP
Wall Street Breakfast: The Week Ahead

This article highlights upcoming events in the financial world, including quarterly earnings reports, IPOs, investor events, and market volatility updates.

Seeking Alpha

Featured Companies: ADI AI ALB AMC AMGN AS ASC AZO BAH BKE CHTR CRNC DELL ELAB ELF ETSY HUMA INTC INTU KMX KRYS LOAR LOW M MDT MRX MSFT NCI NCLH NVDA PANW PARA QCOM RBRK RL RYI SNOW TD TGT TJX TOL TSLA WDAY WOOF ZETA ZM
Should You Buy Gossamer Bio (GOSS) After Golden Cross?

Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?

Zacks Investment Research
5 Penny Stocks To Buy Now According To Insiders

Penny stocks to buy according to these insiders in November 2023. The post 5 Penny Stocks To Buy Now According To Insiders appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

PennyStocks

Featured Companies: ATRA BLDE FTCI PCT

Page data last updated 07/23/2025 09:29:43 UTC